Cargando…
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Autores principales: | Bojkova, Denisa, Stack, Richard, Rothenburger, Tamara, Kandler, Joshua D., Ciesek, Sandra, Wass, Mark N., Michaelis, Martin, Cinatl, Jindrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339084/ https://www.ncbi.nlm.nih.gov/pubmed/35917841 http://dx.doi.org/10.1016/j.jinf.2022.07.023 |
Ejemplares similares
-
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
por: Bojkova, Denisa, et al.
Publicado: (2022) -
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022) -
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
por: Bojkova, Denisa, et al.
Publicado: (2023) -
Lack of antiviral activity of darunavir against SARS-CoV-2
por: De Meyer, Sandra, et al.
Publicado: (2020) -
COVID-19-Related Coagulopathy—Is Transferrin a Missing Link?
por: McLaughlin, Katie-May, et al.
Publicado: (2020)